Needham & Company
-
Needham & Company Reiterates Bicycle Therapeutics (BCYC) at Buy, Focus Remains on BT8009
-
Bicycle Therapeutics Plc (BCYC), Jazz Pharmaceuticals (JAZZ) and SAGE Therapeutics (SAGE) - Needham's Favorite 2022 Biotech Picks
-
Bicycle Therapeutics Plc (BCYC) Data Continues to Trend in the Right Direction - Needham
-
Needham & Company Starts Bicycle Therapeutics (BCYC) at Buy
-
OXURION to Participate in Upcoming Investor Meetings
-
OXURION to Participate in Upcoming Investor Meetings

